143 related articles for article (PubMed ID: 29626472)
1. Tyrosine kinase activity of EphA2 promotes its S897 phosphorylation and glioblastoma cell proliferation.
Hamaoka Y; Negishi M; Katoh H
Biochem Biophys Res Commun; 2018 May; 499(4):920-926. PubMed ID: 29626472
[TBL] [Abstract][Full Text] [Related]
2. EphA2 is a key effector of the MEK/ERK/RSK pathway regulating glioblastoma cell proliferation.
Hamaoka Y; Negishi M; Katoh H
Cell Signal; 2016 Aug; 28(8):937-45. PubMed ID: 27132626
[TBL] [Abstract][Full Text] [Related]
3. Ionizing radiation induces EphA2 S897 phosphorylation in a MEK/ERK/RSK-dependent manner.
Graves PR; Din SU; Ashamalla M; Ashamalla H; Gilbert TSK; Graves LM
Int J Radiat Biol; 2017 Sep; 93(9):929-936. PubMed ID: 28705041
[TBL] [Abstract][Full Text] [Related]
4. The cystine/glutamate antiporter xCT is a key regulator of EphA2 S897 phosphorylation under glucose-limited conditions.
Teramoto K; Katoh H
Cell Signal; 2019 Oct; 62():109329. PubMed ID: 31152846
[TBL] [Abstract][Full Text] [Related]
5. Involvement of EphA2-mediated tyrosine phosphorylation of Shp2 in Shp2-regulated activation of extracellular signal-regulated kinase.
Miura K; Wakayama Y; Tanino M; Orba Y; Sawa H; Hatakeyama M; Tanaka S; Sabe H; Mochizuki N
Oncogene; 2013 Nov; 32(45):5292-301. PubMed ID: 23318428
[TBL] [Abstract][Full Text] [Related]
6. A novel extracellular Hsp90 mediated co-receptor function for LRP1 regulates EphA2 dependent glioblastoma cell invasion.
Gopal U; Bohonowych JE; Lema-Tome C; Liu A; Garrett-Mayer E; Wang B; Isaacs JS
PLoS One; 2011 Mar; 6(3):e17649. PubMed ID: 21408136
[TBL] [Abstract][Full Text] [Related]
7. Serine 897 Phosphorylation of EPHA2 Is Involved in Signaling of Oncogenic ERK1/2 Drivers in Thyroid Cancer Cells.
Allocca C; Cirafici AM; Laukkanen MO; Castellone MD
Thyroid; 2021 Jan; 31(1):76-87. PubMed ID: 32762307
[No Abstract] [Full Text] [Related]
8. Protein kinase C phosphorylates the EphA2 receptor on serine 892 in the regulatory linker connecting the kinase and SAM domains.
Gehring MP; Pasquale EB
Cell Signal; 2020 Sep; 73():109668. PubMed ID: 32413552
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase A can block EphA2 receptor-mediated cell repulsion by increasing EphA2 S897 phosphorylation.
Barquilla A; Lamberto I; Noberini R; Heynen-Genel S; Brill LM; Pasquale EB
Mol Biol Cell; 2016 Sep; 27(17):2757-70. PubMed ID: 27385333
[TBL] [Abstract][Full Text] [Related]
10. Activation of mammalian target of rapamycin complex 1 (mTORC1) and Raf/Pyk2 by growth factor-mediated Eph receptor 2 (EphA2) is required for cholangiocarcinoma growth and metastasis.
Cui XD; Lee MJ; Kim JH; Hao PP; Liu L; Yu GR; Kim DG
Hepatology; 2013 Jun; 57(6):2248-60. PubMed ID: 23315987
[TBL] [Abstract][Full Text] [Related]
11. EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt.
Miao H; Li DQ; Mukherjee A; Guo H; Petty A; Cutter J; Basilion JP; Sedor J; Wu J; Danielpour D; Sloan AE; Cohen ML; Wang B
Cancer Cell; 2009 Jul; 16(1):9-20. PubMed ID: 19573808
[TBL] [Abstract][Full Text] [Related]
12. Filamin A forms a complex with EphA2 and regulates EphA2 serine 897 phosphorylation and glioblastoma cell proliferation.
Tamura Y; Nakamizo Y; Watanabe Y; Kimura I; Katoh H
Biochem Biophys Res Commun; 2022 Mar; 597():64-70. PubMed ID: 35124461
[TBL] [Abstract][Full Text] [Related]
13. Cellular stress induces non-canonical activation of the receptor tyrosine kinase EphA2 through the p38-MK2-RSK signaling pathway.
Zhou Y; Oki R; Tanaka A; Song L; Takashima A; Hamada N; Yokoyama S; Yano S; Sakurai H
J Biol Chem; 2023 May; 299(5):104699. PubMed ID: 37059179
[TBL] [Abstract][Full Text] [Related]
14. EphA2 receptor is a key player in the metastatic onset of Ewing sarcoma.
Garcia-Monclús S; López-Alemany R; Almacellas-Rabaiget O; Herrero-Martín D; Huertas-Martinez J; Lagares-Tena L; Alba-Pavón P; Hontecillas-Prieto L; Mora J; de Álava E; Rello-Varona S; Giangrande PH; Tirado OM
Int J Cancer; 2018 Sep; 143(5):1188-1201. PubMed ID: 29582409
[TBL] [Abstract][Full Text] [Related]
15. Claudin-4 controls the receptor tyrosine kinase EphA2 pro-oncogenic switch through β-catenin.
Shang X; Lin X; Howell SB
Cell Commun Signal; 2014 Oct; 12():59. PubMed ID: 25344320
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of EPHA2 receptor destabilizes adherens junctions via a RhoA-dependent mechanism.
Fang WB; Ireton RC; Zhuang G; Takahashi T; Reynolds A; Chen J
J Cell Sci; 2008 Feb; 121(Pt 3):358-68. PubMed ID: 18198190
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of EphA2 receptor and vasculogenic mimicry is an indicator of poor prognosis in invasive carcinoma of the breast.
Mitra D; Bhattacharyya S; Alam N; Sen S; Mitra S; Mandal S; Vignesh S; Majumder B; Murmu N
Breast Cancer Res Treat; 2020 Jan; 179(2):359-370. PubMed ID: 31686261
[TBL] [Abstract][Full Text] [Related]
18. Activation of the EphA2 tyrosine kinase stimulates the MAP/ERK kinase signaling cascade.
Pratt RL; Kinch MS
Oncogene; 2002 Oct; 21(50):7690-9. PubMed ID: 12400011
[TBL] [Abstract][Full Text] [Related]
19. The protein kinase C-eta isoform induces proliferation in glioblastoma cell lines through an ERK/Elk-1 pathway.
Uht RM; Amos S; Martin PM; Riggan AE; Hussaini IM
Oncogene; 2007 May; 26(20):2885-93. PubMed ID: 17146445
[TBL] [Abstract][Full Text] [Related]
20. Emerging and Diverse Functions of the EphA2 Noncanonical Pathway in Cancer Progression.
Zhou Y; Sakurai H
Biol Pharm Bull; 2017; 40(10):1616-1624. PubMed ID: 28966234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]